Signalling mechanisms regulating the activation of human eosinophils by mast-cell-derived chymase: implications for mast cell-eosinophil interaction in allergic inflammation.
Allergic diseases such as asthma and allergic dermatitis are associated with the degranulation of mast cells. Chymase, a mast-cell-specific protease, is the major component in mast cell granules that can induce eosinophil infiltration into inflammatory sites. We examined the immunopathological mechanisms for the activation of eosinophils by chymase in allergic inflammation. Cytokines were measured by cytometric bead array Flex Sets multiplex assay using flow cytometry and enzyme-linked immunosorbent assay. Adhesion molecules, migration and intracellular signalling pathways were assessed by flow cytometry, Boyden chamber assay and Western blot, respectively. Chymase suppressed the apoptosis of eosinophils and induce the release of the cytokine interleukin-6 (IL-6) and chemokines CXCL8, CCL2 and CXCL1 by eosinophils dose-dependently. It also up-regulated the surface expression of adhesion molecule CD18 and stimulated the chemokinetic migration of eosinophils. The expressions of adhesion molecules, cytokines and chemokines, and chemokinetic migration were differentially regulated by the activation of extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, Akt, Janus-activated kinase and nuclear factor-kappaB pathways. Chymase therefore plays a pivotal immunological role in the interaction between mast cells and eosinophils in allergic diseases such as allergic dermatitis by inducing adhesion molecule-mediated chemokinetic migration and inflammatory cytokines and chemokines of eosinophils, through multiple intracellular signalling molecules and transcription factor. Our results therefore provide a further biochemical basis for the pathogenesis of allergic inflammation consequent on the interaction between mast cells and eosinophils, and give insight for the development of new therapies.
Wong
Chun K
CK
Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. ck-wong@cuhk.edu.hk
Ng
Sinnie S M
SS
Lun
Samantha W M
SW
Cao
Ju
J
Lam
Christopher W K
CW
D018821:CD18 Antigens / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002450:Cell Communication / Q000276:immunology; D002470:Cell Survival / Q000276:immunology; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D053818:Chymases / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism; D004789:Enzyme Activation / Q000276:immunology; D004804:Eosinophils / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007249:Inflammation / Q000276:immunology*; D008407:Mast Cells / Q000201:enzymology* / Q000276:immunology; D016328:NF-kappa B / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011994:Recombinant Proteins / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D015854:Up-Regulation / Q000276:immunology
D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; D016207:Cytokines; D016328:NF-kappa B; D011994:Recombinant Proteins; D011505:Protein-Tyrosine Kinases; D053818:Chymases
J Immunol. 2000 Nov 15;165(10):5814-21
11067941
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1858-63
15976326
Eur J Pharmacol. 2006 May 24;538(1-3):175-81
16690053
J Interferon Cytokine Res. 2004 May;24(5):271-81
15153310
Adv Clin Chem. 2003;37:1-46
12619704
J Leukoc Biol. 2000 Apr;67(4):585-9
10770293
Int Immunol. 2006 Aug;18(8):1327-35
16798840
J Allergy Clin Immunol. 2004 Nov;114(5):997-1008; quiz 1009
15536399
Am J Respir Cell Mol Biol. 1998 Sep;19(3):408-18
9730868
J Allergy Clin Immunol. 2001 Oct;108(4):581-7
11590385
FASEB J. 2003 Nov;17(14):2139-41
14500550
J Allergy Clin Immunol. 2006 Jul;118(1):24-34; quiz 35-6
16815134
J Allergy Clin Immunol. 2006 Jul;118(1):178-89
16815153
Immunol Rev. 2001 Feb;179:163-72
11292020
Nat Rev Drug Discov. 2006 Jul;5(7):549-63
16773072
Clin Exp Immunol. 2000 Jul;121(1):31-6
10886236
Clin Exp Immunol. 2004 Dec;138(3):375-87
15544612
Am J Respir Crit Care Med. 2005 May 15;171(10):1103-8
15879427
J Invest Dermatol. 1995 Jul;105(1 Suppl):20S-24S
7615993
J Leukoc Biol. 1997 Mar;61(3):233-45
9060446
Immunol Rev. 2007 Jun;217:141-54
17498057
Eur J Immunol. 2007 Aug;37(8):2337-48
17634954
J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S450-6
16455345
Int Arch Allergy Immunol. 2002 Jul;128(3):229-34
12119505
Biochem Biophys Res Commun. 2005 Jul 15;332(4):969-75
15919053
J Immunol. 1998 Jun 1;160(11):5554-62
9605160
Allergy Asthma Proc. 2002 Sep-Oct;23(5):331-5
12476543
Arch Dermatol Res. 2005 Apr;296(10):503-6
15703960
J Allergy Clin Immunol. 2006 Jun;117(6):1277-84
16750987
Int J Legal Med. 2005 Nov;119(6):331-4
15735956
J Immunol. 2002 Sep 1;169(5):2662-9
12193739
Int Arch Allergy Immunol. 2001 Aug;125(4):344-8
11574757
Allergy. 2006 Jul;61(7):878-85
16792588
Ann N Y Acad Sci. 1996 Oct 31;796:9-20
8906207
IDrugs. 2002 Dec;5(12):1141-50
12800055
Am J Respir Cell Mol Biol. 2005 Aug;33(2):186-94
15860795
Br J Pharmacol. 1998 Dec;125(7):1491-500
9884078
Lab Invest. 2002 Jun;82(6):789-94
12065690
Int Arch Allergy Immunol. 2004 Nov;135(3):196-204
15467372
Jpn J Pharmacol. 2002 Nov;90(3):214-7
12499574